Clinical trial for Head and Neck Cancer
Official title Survivorship After HNC: A Randomized Controlled Trial Evaluating Patient Care and Adherence to Follow-up
ClinicalTrials.gov ID: NCT06127784
What this study is testing
- What it's testing
- This study is testing whether a survivorship care plan plus a counseling session improves how well doctors follow care recommendations for head and neck cancer survivors.
- Who it's for
- You may be able to join if you have finished treatment for head or neck cancer and are followed at the London Regional Cancer Program.
- What's involved
- You would receive a written survivorship care plan and a one‑on‑one counseling talk with a nurse. You will also answer surveys about your health and care.
- Time commitment
- The study lasts about 12 months with visits at the start and later check‑ins.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient Participants
- Age 18 years or older
- Willing to provide informed consent
- Diagnosis of stage I-IVA head and neck mucosal cancer (larynx, hypopharynx, oral cavity, oropharynx, nasopharynx)
- Last definitive treatment (surgery, chemotherapy, radiotherapy) between 3 and 6 months prior to enrollment
You likely can't join if
- Second concurrent non-cutaneous malignancy
- Metastatic disease
- Clinically apparent cognitive impairment
- Suspected residual disease after treatment completion
See the full eligibility criteria
- Patient Participants
- Age 18 years or older
- Willing to provide informed consent
- Diagnosis of stage I-IVA head and neck mucosal cancer (larynx, hypopharynx, oral cavity, oropharynx, nasopharynx)
- Last definitive treatment (surgery, chemotherapy, radiotherapy) between 3 and 6 months prior to enrollment
- English speaking, reading and writing
- Second concurrent non-cutaneous malignancy
- Metastatic disease
- Clinically apparent cognitive impairment
- Suspected residual disease after treatment completion
The study team makes the final eligibility decision.
Where it is enrolling
- London, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at London, Ontario, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.